Inspire Medical Systems, Inc.
INSP
$52.07
-$0.09-0.17%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.25% | 10.49% | 10.82% | 22.75% | 24.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.25% | 10.49% | 10.82% | 22.75% | 24.52% |
| Cost of Revenue | 0.23% | -1.93% | 16.18% | 24.04% | 28.28% |
| Gross Profit | 14.37% | 12.84% | 9.86% | 22.52% | 23.88% |
| SG&A Expenses | 14.45% | 21.84% | 20.77% | 14.86% | 14.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.28% | 13.76% | 15.52% | 13.15% | 13.44% |
| Operating Income | 44.62% | -32.64% | -165.03% | 90.24% | 242.95% |
| Income Before Tax | 37.35% | -33.33% | -121.50% | 144.46% | 140.39% |
| Income Tax Expenses | -6,174.43% | 97.87% | 19.66% | 79.54% | 196.02% |
| Earnings from Continuing Operations | 286.36% | -46.30% | -136.68% | 129.91% | 138.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 286.36% | -46.30% | -136.68% | 129.91% | 138.60% |
| EBIT | 44.62% | -32.64% | -165.03% | 90.24% | 242.95% |
| EBITDA | 45.31% | -17.61% | -98.49% | 110.84% | 239.75% |
| EPS Basic | 298.17% | -45.31% | -136.95% | 129.81% | 136.13% |
| Normalized Basic EPS | 30.16% | -11.83% | -84.08% | 144.33% | 137.90% |
| EPS Diluted | 308.36% | -43.57% | -138.03% | 129.41% | 132.40% |
| Normalized Diluted EPS | 32.93% | -10.39% | -83.71% | 143.47% | 136.38% |
| Average Basic Shares Outstanding | -2.97% | -1.83% | -0.75% | 0.29% | 1.05% |
| Average Diluted Shares Outstanding | -4.99% | -3.37% | -2.96% | 2.35% | 1.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |